The Carvacrol-injected and mixed groups (##P ≤ 0.01 vs. tumor, NS vs. normal) demonstrated the greatest amelioration of ALT activities relative to oral treatment (#P ≤ 0.05 vs. tumor, *P ≤ 0.05). This evidence concerns the gene GPT and neoplasm.